bioAffinity Technologies Inc (BIAF) Stock Price & News

All values in USD	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	1.27M	1.45M	1.59M	1.35M
Cost of goods sold	1.02M	942.21K	900.13K	928.64K
Cost of revenue	1.02M	942.21K	900.13K	928.64K
Research and development expenses	440.65K	473.90K	668.81K	683.75K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.21M	2.21M	3.04M	3.24M
Operating expense	2.77M	2.80M	3.83M	4.04M
Total operating expenses	3.79M	3.74M	4.73M	4.97M
Operating income	-2.52M	-2.29M	-3.14M	-3.62M
Other non operating income	-1.51M	-2.75M	-3.98K	-8.94K
EBT including unusual items	-4.03M	-5.05M	-3.13M	-3.63M
EBT excluding unusual items	-4.03M	-5.05M	-3.13M	-3.63M
Income tax expense	28.98K	3.18K	3.18K	-
Effective tax rate	-0.72%	-0.06%	-0.10%	-
Other operating expenses	-	-	-	-
Net income	-4.06M	-5.05M	-3.14M	-3.63M
Net profit margin	-319.88%	-349.30%	-196.98%	-268.63%
Earnings per share	-5.10	-4.74	-	-
Interest and investment income	2.02K	1.09K	19.73K	10.03K
Interest expense	-10.46K	-5.36K	-13.07K	-14.72K
Net interest expenses	-8.44K	-4.27K	6.66K	-4.70K
Depreciation and amortization charges	113.23K	113.36K	123.66K	114.52K
EBITDA	-2.31M	-2.18M	-3.01M	-3.49M
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

Finance